Recent Material Events

Track the latest material events (8-K filings) with AI-powered analysis. Stay informed about major corporate developments, acquisitions, and changes.

πŸ“Š 926 Events
πŸ€– AI Analyzed
Recent
πŸ“„ Page 11 of 78
Nuwellis, Inc.
8-K March 27, 2026

Key Highlights

  • Proprietary Aquadex SmartFlow system for fluid overload management
  • Annual revenue generation of $20 million to $25 million
  • Strategic focus on medical technology growth and market penetration
Read Analysis
πŸ€– AI Generated

Key Highlights

  • Strategic cooperation agreement with activist investor Elliott Investment Manage...
  • Major board overhaul adding five independent directors with expertise in turnaro...
  • Increased focus on operational efficiency and aggressive debt reduction.
Read Analysis
πŸ€– AI Generated

Key Highlights

  • Focus on programmatic advertising and publisher monetization
  • Strategic decision to prioritize operational cash over listing compliance
  • Avoidance of dilutive reverse stock splits to preserve shareholder value
Read Analysis
πŸ€– AI Generated
Pulmatrix, Inc.
8-K March 27, 2026

Key Highlights

  • Strategic pivot to high-growth senolytic longevity therapies
  • Reverse takeover by Eos SENOLYTIX to access public markets
  • Significant $18 million capital injection for clinical trials
Read Analysis
πŸ€– AI Generated
CareCloud, Inc.
8-K March 27, 2026

Key Highlights

  • Operational stability maintained with no permanent loss of data or system functi...
  • Breach isolated to a single EHR environment, leaving five other systems and corp...
  • Cybersecurity insurance in place to mitigate forensic, legal, and remediation co...
Read Analysis
πŸ€– AI Generated
Cue Biopharma, Inc.
8-K March 27, 2026

Key Highlights

  • Appointment of Lucinda Warren as Interim CEO, leveraging her 25-year J&J backgro...
  • Strategic pivot toward business development, potential asset sales, and partners...
  • Narrowed research focus on the lead drug candidate, CUE-101, to optimize resourc...
Read Analysis
πŸ€– AI Generated

Key Highlights

  • Company is appealing a Nasdaq 'Qualification Halt' to resume trading
  • Share count correction to 227,554 following 1-for-100 reverse split
  • Anticipated increase in public float via brokerage 'round-up' of fractional shar...
Read Analysis
πŸ€– AI Generated
Iterum Therapeutics plc
8-K March 27, 2026

Key Highlights

  • FDA approval of ORLYNVAHβ„’ achieved on October 25, 2024
  • Company has filed a petition for liquidation in the Irish High Court
  • Appointment of Joint Provisional Liquidators to manage asset sales
Read Analysis
πŸ€– AI Generated

Key Highlights

  • Strategic pivot toward high-margin proprietary brands like Phantom and HEAVY 16
  • Aggressive operational downsizing to align with current market demand
  • Consolidation of manufacturing and distribution to improve efficiency
Read Analysis
πŸ€– AI Generated
Burford Capital Ltd
8-K March 27, 2026

Key Highlights

  • Core business remains robust with $450 million in annual profit.
  • Diversified portfolio of over 200 legal cases beyond the YPF litigation.
  • Active pursuit of alternative international arbitration to recover value.
Read Analysis
πŸ€– AI Generated
BiomX Inc.
8-K March 27, 2026

Key Highlights

  • Developing innovative phage therapies for cystic fibrosis and chronic sinus issu...
  • Active clinical research pipeline including the BX004 program
  • Potential for future value creation through strategic partnerships or buyouts
Read Analysis
πŸ€– AI Generated
GIFTIFY, INC.
8-K March 27, 2026

Key Highlights

  • Nasdaq non-compliance notice regarding minimum $1.00 share price
  • 180-day grace period to regain compliance by September 23, 2026
  • Potential for reverse stock split to maintain exchange listing
Read Analysis
πŸ€– AI Generated

Stay Informed with AI Analysis

Get comprehensive insights from material event filings with our AI-powered analysis. Track corporate developments, acquisitions, and strategic changes.

Back to Homepage